PTC Therapeutics (PTCT) Stock News

$PTCT · NASDAQ · 2 stories in 30 days

BORSA has published 2 stories on PTC Therapeutics (PTCT) in the past 30 days. BORSA’s news read on PTCT is balanced at 50/100, based on 1 company event over the past 7 days. PTCT last closed at $59.92 on Oct 13, down 5.93% over five sessions and down 9.87% over the past month. PTC Therapeutics’ next earnings report is scheduled for Thursday, Oct 29 after the close.

The wire on $PTCT

newest first · updated Oct 16, 8:04 AM ET · direct subject stories only

Analyst actionOct 16 · 8:04 AM ET

Truist initiates PTC Therapeutics coverage with Hold rating and $62 price target

Truist initiated coverage on PTC Therapeutics.

neutral 50 · impact 30

PTC Therapeutics is shown as a pill bottle with a coin balanced on top, suggesting a neutral analyst rating.

← Stocks · in the newsroom

PTC Therapeutics (PTCT) Stock News

$PTCT · NASDAQ · 2 stories in 30 days

The wire on $PTCT

newest first · updated Oct 16, 8:04 AM ET · direct subject stories only

Analyst actionOct 16 · 8:04 AM ET

Truist initiates PTC Therapeutics coverage with Hold rating and $62 price target

Truist initiated coverage on PTC Therapeutics.

neutral 50 · impact 30

Frozen company-score outcomes

One recorded score per stock and trading day. Evidence and method are fixed before the measured returns. Later news cannot rewrite those predictions.

Horizon	Coverage	Vs SPY match	Vs sector match	Stock median	Vs SPY median	Vs sector median
1 hour	0 measured · 0 days · 0 pending · 9 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—
Next session close	0 measured · 0 days · 0 pending · 9 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—
Fifth subsequent session close	0 measured · 0 days · 0 pending · 9 unavailable	Collecting (0/30)	Collecting (0/30)	—	—	—

Method ticker-news-v4. Direction match appears only after 30 scored trading days per horizon. Neutral scores and benchmark moves within ±0.05% are unscored. Five-session outcomes overlap; observations are not independent trials. These are price returns, not dividend-reinvested returns. This is observation, not established predictive accuracy.

PTC Therapeutics (PTCT) Stock News

The wire on $PTCT

PTC Therapeutics (PTCT) Stock News

The wire on $PTCT

The wire on this name is open. What the tape did about it is one free account away.

PTC Therapeutics (PTCT) stock: common questions

What is the latest PTC Therapeutics stock news?

Is the news on PTCT bullish or bearish?

When does PTC Therapeutics report earnings?

How has PTCT stock moved recently?

Frozen company-score outcomes